LOUISA FARLEY: Open Payments
NPI 1275827495 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 34 payments from 11 companies in 2025. Trend: 2023 $219 · 2024 $382 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| PFIZER INC. | 3 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $35 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
Products named: QULIPTA, CAPLYTA, UBRELVY, LEQVIO, VOQUEZNA, TRELEGY ELLIPTA, Auvelity, NURTEC ODT.
Industry payments across KY — which companies pay providers there.
